Horizon Discovery plc Доход
Что обозначает Доход в Horizon Discovery plc?
Доход Horizon Discovery Group plc является £54.630M
Какое определение для Доход?
Доход - это прибыль, которую бизнес получает от обычной деловой деятельности, обычно от продажи товаров и предоставления услуг клиентам.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Доход компаний в Health Care сектор на LSE по сравнению с Horizon Discovery plc
Что делает Horizon Discovery plc?
Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.
Компании с доход похож на Horizon Discovery plc
- Gresham House Storage Fund PLC имеет Доход из £54.520M
- Aifinyo Ag Inh O.N имеет Доход из €54.530M
- Bitcoin Well Inc имеет Доход из CAD$54.530M
- Charlotte's Web имеет Доход из $54.540M
- Charlotte's Web имеет Доход из $54.540M
- CML имеет Доход из AUD$54.560M
- Horizon Discovery plc имеет Доход из £54.630M
- i-80 Gold имеет Доход из $54.650M
- Canntrust Inc имеет Доход из CAD$54.658M
- Electromed имеет Доход из $54.716M
- Huanxi Media имеет Доход из HKD$54.720M
- China Bozza Development имеет Доход из ¥54.720M
- Class имеет Доход из AUD$54.784M